Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Quadrise

    MCap

    GBP30m

    Last close

    GBP0.01

    ▲ 0.37 (34.26%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    Chosa

    MCap

    SEK50m

    Last close

    SEK0.54

    ▲ 0.07 (15.32%)

  • Sectors

    Sectors

    View All Sectors
  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Sparks commentary - VinFast Auto

Industrials

Sparks - VinFast Auto

More on this equity
VinFast (NASDAQ: VFS) – Q3 deliveries more than double y-o-y as founder provides further capital support
Published by Harry Kilby

VinFast has announced preliminary Q326 global deliveries ahead of its Q326 results on 2 December 2026. Electric vehicle (EV) deliveries increased 116% y-o-y to 82,580 units, taking deliveries in the first nine months of 2026 (9M26) to 211,242, up 91% y-o-y. The VF 3 and Limo Green were the largest contributors in the quarter, with 21,744 and 19,100 deliveries, respectively, followed by the VF 5 at 10,329 units and VF 6 at 7,519 units. VinFast also delivered 284,831 e-scooters and e-bikes in Q326, up 137% y-o-y, including 281,409 units in Vietnam, taking 9M26 two-wheeler deliveries to 714,006, up 204% y-o-y. The Evo and Feliz accounted for c 57% and 26% of two-wheeler deliveries, respectively.

Alongside the delivery update, on the 29 October 2026, founder and director Pham Nhat Vuong made an additional VND11,000bn, or c US$436.4m, capital contribution to VinFast Vietnam through the issuance of dividend preference shares with no conversion, exchange or similar rights. The shares have the same terms as those issued to him in Q326, with the additional funding intended to strengthen VinFast Vietnam’s capital base and support its strategic growth initiatives.

Next Sparks Commentary in this sector >

Latest

Healthcare | Comment

Percheron Therapeutics (ASX:PER): FDA clears AML trial

Industrials | Comment

Amoéba (PAR: ALMIB) – H126 confirmed and financing completed

Energy & Resources | Comment

bp (LSE: BP) – completes Castrol transaction, with $6bn proceeds supporting balance sheet reduction

Healthcare | Comment

OSE Immunotherapeutics (PAR: OSE) adds depth to Combi-TED survival signal

Metals & Mining | Comment

Leading Edge Materials (TSXV: LEM) – EIA commencement advances Norra Kärr permitting and project de-risking
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.